fibrinogen has been researched along with Cardiac Diseases in 69 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (20.29) | 18.7374 |
1990's | 16 (23.19) | 18.2507 |
2000's | 25 (36.23) | 29.6817 |
2010's | 12 (17.39) | 24.3611 |
2020's | 2 (2.90) | 2.80 |
Authors | Studies |
---|---|
Araki, Y; Goto, S; Hattori, M; Izumi, T; Matsushita, T; Nishihori, M; Saito, R; Suzuki, N; Tamura, S; Uda, K; Yokoyama, K | 1 |
Hu, X; Li, P; Xu, J; Zheng, H | 1 |
Dagnelie, PC; Derom, C; Gerver, WJ; Gielen, M; Houben, AJ; Loos, RJ; Mulder, AL; Stehouwer, CD; Touwslager, RN; Vlietinck, R; Zeegers, MP; Zimmermann, LJ | 1 |
Hsia, TC; Mong, MC; Yin, MC | 1 |
Jilma, B; Kulinna-Cosentini, C; Laggner, A; Röggla, M; Schober, A; Schörgenhofer, C; Schwameis, M; Thaler, J | 1 |
Bolliger, D; Fassl, J; Filipovic, M; Hampl, K; Lurati Buse, G; Reuthebuch, O; Seeberger, MD | 1 |
Gil, L; Grajek, S; Komarnicki, M; Rupa-Matysek, J; Szczepaniak-Chicheł, L; Trojnarska, O; Tykarski, A; Wojtasińska, E | 1 |
Meus, R; Sobczyk, D; Son, M; Undas, A | 1 |
Sinatra, DS; Sinatra, ST | 1 |
Baryshnikova, E; Frigiola, A; Menicanti, L; Pistuddi, V; Ranucci, M | 1 |
Casanova-Borca, A; Catena, C; Chiuch, A; Colussi, G; Di Fabio, A; Nadalini, E; Novello, M; Sechi, LA; Uzzau, A | 1 |
Delabre, JP; Garrigue, V; Mourad, G | 1 |
Nordestgaard, BG; Tybjaerg-Hansen, A; Zacho, J | 1 |
Emich-Widera, E; Kopyta, I; Marszał, E; Sarecka-Hujar, B; Zak, I | 1 |
Domashenko, MA; Ionova, VG; Maksimova, MIu; Mikhal'chenko, VN; Okhtova, FR; Syskina, EN | 1 |
Elyakoubi, J; Gruszka, A; Hermanns-Sachweh, B; Kuschel, TJ; Sachweh, JS; Schnoering, H; Vázquez-Jiménez, JF | 1 |
Matsuda, M; Matsui, H; Miyata, S; Mizuno, T; Sugimoto, M; Tsuji, S; Yoshioka, A | 1 |
Best, L; Celentano, A; de Simone, G; Devereux, RB; Fabsitz, RR; Howard, BV; Lewis, MR; Palmieri, V; Robbins, DC; Roman, MJ | 1 |
Chrysohoou, C; Das, UN; Panagiotakos, DB; Pitsavos, C; Stefanadis, C | 1 |
Davenport, RJ | 1 |
Gau, G | 1 |
Carey, HM; Carter, TR; Elliott, MJ; Kull, AD; Morel-Kopp, MC; Philcox, S; Schenck, K; Taylor, BA; Tofler, GH; Ward, C | 1 |
Aljassim, O; Berglin, E; Jeppsson, A; Karlsson, M; Olsson, P; Wiklund, L | 1 |
Franz, M; Grønbaek, M; Jensen, MK; Koh-Banerjee, P; Rimm, EB; Sampson, L | 1 |
Balion, C; Bickel, C; Blankenberg, S; Cambien, F; Gerstein, H; Lonn, E; McQueen, MJ; Münzel, T; Pogue, J; Rupprecht, HJ; Smieja, M; Tiret, L; Yusuf, S | 1 |
Eshigina, S; Gapparov, MM; Kulakov, SN; Mal'tsev, GIu | 1 |
Feher, G; Kesmarky, G; Koltai, K; Toth, K | 1 |
Bliss, R; Carmella, SG; Gross, M; Hatsukami, DK; Hecht, SS; Joseph, AM; Lando, H; Le, CT; Murphy, SE | 1 |
Otto, C; Richter, WO | 1 |
Lip, GY | 1 |
Albertsson, M; Cwikiel, M; Eskilsson, J; Larsson, H; Persson, SU | 1 |
Crook, MA; Pickup, JC | 1 |
Lee, AJ; Lowe, GD; Tunstall-Pedoe, H; Woodward, M | 1 |
Bolibar, I; Fechtrup, C; Kienast, J; Matthias, R; Niessner, H; Thompson, SG | 1 |
Astedt, B; Lecander, I; Lindoff, C; Martinsson, G; Peterson, F | 1 |
Fowkes, FG; Lee, AJ; Lowe, GD; Price, JF; Rumley, A; Smith, FB | 1 |
Ban, K; Ishii, O; Kanzaki, Y; Komiya, T; Nakamura, T; Yamazaki, K | 1 |
Fukazawa, H; Ikesa, U; Shimada, K; Yamamoto, K | 1 |
Beckman, EJ; Deible, CR; Johnson, PC; Petrosko, P; Russell, AJ; Wagner, WR | 1 |
Giddings, JC; Hashimoto, M; Kawano, M; Sasaki, Y; Taka, T; Watanabe, S; Yamamoto, J; Yamashita, T | 1 |
Butterly, RJ; Carroll, S; Cooke, CB | 1 |
Rader, DJ | 1 |
Blann, AD; Gibbs, CR; Lip, GY; Watson, RD | 1 |
Weitzman, J | 1 |
Chen, R; Curb, JD; Grove, JS; Rodriguez, BL; Tracy, RP; Yano, K | 1 |
Asayama, K; Kohri, T; Otabe, T; Sakai, M; Shirahata, A | 1 |
Jousimies-Somer, H; Lindqvist, C; Meurman, JH; Suuronen, R; Ylijoki, S | 1 |
Gladdish, S; Rajkumar, C | 1 |
Hamilton, A; Huang, SL; Kane, B; Klegerman, M; MacDonald, R; Madhav, T; McPherson, D; Nagaraj, A; Rabbat, M; Stein, A; Warnick, D | 1 |
Acevedo, M; Kottke-Marchant, K; Pearce, GL; Sprecher, DL | 1 |
Isomura, K | 1 |
Borda, IT; Inwood, MJ; Lam, A; Thomson, S | 1 |
Rhodes, GR; Silver, D | 1 |
Araújo, A; Ferreira, D; Geraldes, MJ; Monteiro, J; Nunes, V; Pais, F; Perdigão, C; Ribeiro, C; Varela, MG | 1 |
Sutherland, S; Tibballs, J | 1 |
Erickson, D | 1 |
Bastien, O; Champsaur, G; Cochet, P; d'Agrosa, MC; de Riberolles, C; Neidecker, J; Ninet, J; Vigneron, M | 1 |
Tilsner, V | 1 |
Matsuyama, K; Miyagi, H; Ogawa, H; Okumura, K; Oshima, S; Yasue, H | 1 |
Kinoshita, M; Sakoda, S; Suzuki, T | 1 |
McShane, P; Vetta, A | 1 |
Dasaev, AN; Fakhradov, TN; Gebel', GIa; Lilloson, AA; Utkin, VN | 1 |
Akioka, K; Hirota, K; Itagane, H; Ochi, H; Oku, H; Takeda, T; Takeuchi, K; Teragaki, M; Yasuda, M | 1 |
Belanger, AJ; D'Agostino, RB; Kannel, WB | 1 |
Douglas, AS; Ogston, D; Rawles, JM | 1 |
Gabryelewicz, A; Poplawski, A; Prokopowicz, J; Worowski, K | 1 |
Komp, DM; Sparrow, AW | 1 |
Medvedeva, ZF; Shishkova, TV; Vorob'ev, AI | 1 |
2 review(s) available for fibrinogen and Cardiac Diseases
Article | Year |
---|---|
Fibrinogen and cardiovascular disorders.
Topics: Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Female; Fibrinogen; Gonadal Steroid Hormones; Heart Diseases; Humans; Hyperlipidemias; Hypertension; Male; Risk Factors; Smoking | 1995 |
Prevention of cardiac disease in the elderly.
Topics: Aged; Diabetes Complications; Exercise; Fibrinogen; Heart Diseases; Homocysteine; Humans; Hypertension; Lipids; Obesity; Risk Factors; Smoking Cessation; United Kingdom; Vitamin E | 2001 |
6 trial(s) available for fibrinogen and Cardiac Diseases
Article | Year |
---|---|
Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Coagulation; Blood Pressure; C-Reactive Protein; Cholesterol, HDL; Diet, Mediterranean; Female; Fibrinogen; Greece; Heart Diseases; Homocysteine; Humans; Inflammation Mediators; Interleukin-6; Leukocyte Count; Male; Middle Aged; Reference Values; Risk Factors; Serum Amyloid A Protein; Treatment Outcome; Triglycerides; Tumor Necrosis Factor-alpha | 2004 |
Inflammatory response and platelet activation after off-pump coronary artery bypass surgery.
Topics: Aged; beta-Thromboglobulin; Complement C3a; Coronary Artery Bypass, Off-Pump; Female; Fibrinogen; Heart Diseases; Hematocrit; Hemostasis; Humans; Leukocyte Elastase; Male; Middle Aged; Platelet Activation; Postoperative Hemorrhage; Postoperative Period | 2006 |
Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Female; Fibrinogen; Heart Diseases; Humans; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Predictive Value of Tests; Ramipril; Risk Factors; Vitamin E | 2006 |
Smoking reduction fails to improve clinical and biological markers of cardiac disease: a randomized controlled trial.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Carbon Monoxide; Cotinine; F2-Isoprostanes; Female; Fibrinogen; Glucuronides; Heart Diseases; Humans; Male; Middle Aged; Nitrosamines; Pyrenes; Pyridines; Smoking; Smoking Cessation; Smoking Prevention | 2008 |
Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
Topics: Aged; Cholesterol, HDL; Double-Blind Method; Drug Administration Schedule; Endometrial Hyperplasia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinogen; Glucose; Heart Diseases; Humans; Insulin; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Risk Factors; Systole; Weight Gain | 1995 |
Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Arrhythmia, Sinus; Blood Platelets; Chronic Disease; Cohort Studies; Cross-Sectional Studies; Endothelium, Vascular; Female; Fibrinogen; Heart Diseases; Hematocrit; Humans; Lisinopril; Male; Middle Aged; P-Selectin; Platelet Count; Regression Analysis; Rheology; Sex Characteristics; Solubility; Statistics, Nonparametric; Viscosity; von Willebrand Factor | 2001 |
61 other study(ies) available for fibrinogen and Cardiac Diseases
Article | Year |
---|---|
Medical Management of a Mural Thrombus Inducing Repeated Ischemic Strokes in a Patient with Congenital Afibrinogenemia.
Topics: Afibrinogenemia; Female; Fibrinogen; Heart Diseases; Hemorrhage; Humans; Ischemic Stroke; Middle Aged; Thrombosis | 2022 |
Correlation of Serum Clara Cell Secretory Protein 16, Plasma Fibrinogen and Serum Amyloid A with the Severity of Acute Exacerbated COPD and Their Combination in Prognosis Assessment.
Topics: Fibrinogen; Heart Diseases; Humans; Prognosis; Pulmonary Disease, Chronic Obstructive; Quality of Life; Serum Amyloid A Protein; Uteroglobin | 2023 |
Genetic and environmental factors in associations between infant growth and adult cardiometabolic risk profile in twins.
Topics: Adolescent; Adult; Belgium; Blood Glucose; Blood Pressure; Child, Preschool; Environment; Female; Fibrinogen; Heart Diseases; Humans; Infant; Infant, Newborn; Insulin Resistance; Leptin; Lipids; Male; Metabolic Diseases; Prospective Studies; Risk Factors; Triglycerides; Twins; Twins, Dizygotic; Twins, Monozygotic; Weight Gain | 2013 |
Dietary trans fats enhance doxorubicin-induced cardiotoxicity in mice.
Topics: Animals; Antithrombin III; C-Reactive Protein; Cardiotoxins; Chemokine CCL2; Creatine Kinase; Dietary Fats; Doxorubicin; Fibrinogen; Heart Diseases; Interleukin-10; Interleukin-6; L-Lactate Dehydrogenase; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; Plasminogen Activator Inhibitor 1; Protein C; Reactive Oxygen Species; RNA, Messenger; Trans Fatty Acids; Transcription Factor RelA; Triglycerides; Tumor Necrosis Factor-alpha; Up-Regulation | 2013 |
Tranexamic acid and fibrinogen restore clotting in vitro and in vivo in cardiac thrombus associated hyperfibrinolysis with overt bleedings.
Topics: Adenocarcinoma; Aged; Anemia; Antifibrinolytic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Carcinoma, Squamous Cell; Cecal Neoplasms; Disseminated Intravascular Coagulation; Fatal Outcome; Female; Fibrinogen; Fibrinolysis; Fluorouracil; Heart Diseases; Hemorrhage; Humans; Leucovorin; Lung Neoplasms; Lymphatic Metastasis; Multiple Organ Failure; Neoplasms, Multiple Primary; Organoplatinum Compounds; Postoperative Complications; Thrombosis; Tranexamic Acid; Vulvar Neoplasms | 2014 |
Perioperative administration of fibrinogen does not increase adverse cardiac and thromboembolic events after cardiac surgery.
Topics: Aged; Cardiac Surgical Procedures; Cohort Studies; Female; Fibrinogen; Follow-Up Studies; Heart Diseases; Hemostatics; Hospital Mortality; Humans; Incidence; Male; Middle Aged; Perioperative Care; Postoperative Complications; Prospective Studies; Retrospective Studies; Thromboembolism | 2015 |
Assessment of coagulation profile by thromboelastometry in adult patients with cyanotic congenital heart disease.
Topics: Adult; Aged; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Cyanosis; Female; Fibrinogen; Fibrinolysis; Heart Diseases; Hemorrhage; Hemostatic Techniques; Humans; Male; Middle Aged; Partial Thromboplastin Time; Perioperative Care; Prothrombin Time; Thrombelastography; Thrombosis; Warfarin; Young Adult | 2016 |
Prothrombotic State in Patients With a Left Atrial Appendage Thrombus of Unknown Origin and Cerebrovascular Events.
Topics: Adult; Anticoagulants; Atrial Appendage; Atrial Fibrillation; Blood Coagulation Factors; Brain Ischemia; Case-Control Studies; Comorbidity; Endothelium, Vascular; Female; Fibrinogen; Fibrinolysis; Follow-Up Studies; Foramen Ovale, Patent; Heart Diseases; Humans; Ischemic Attack, Transient; Male; Middle Aged; Migraine Disorders; Platelet Count; Smoking; Stroke Volume; Thrombin; Thrombophilia; Thrombosis | 2016 |
Inflammation and the Heart: A Commentary.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; C-Reactive Protein; Fibrinogen; Heart Diseases; Humans; Inflammation; Lipoproteins; Peroxidase | 2016 |
The effectiveness of 10 years of interventions to control postoperative bleeding in adult cardiac surgery.
Topics: Aged; Blood Coagulation Factors; Blood Transfusion; Cardiac Surgical Procedures; Clinical Protocols; Female; Fibrinogen; Heart Diseases; Humans; Male; Middle Aged; Plasma; Platelet Transfusion; Postoperative Hemorrhage; Retrospective Studies; Thrombelastography; Time Factors; Treatment Outcome | 2017 |
Relationship of plasma renin with a prothrombotic state in hypertension: relevance for organ damage.
Topics: Adult; Aldosterone; Algorithms; Analysis of Variance; Biomarkers; Cerebrovascular Disorders; Cross-Sectional Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Diseases; Humans; Hypertension; Italy; Kidney Diseases; Male; Middle Aged; Peptide Fragments; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Prothrombin; Regression Analysis; Renin; Renin-Angiotensin System; Risk Factors; Serine Proteinase Inhibitors | 2008 |
Cardiac amyloidosis with the E526V mutation of the fibrinogen A alpha-chain.
Topics: Amyloid; Amyloidosis, Familial; Biopsy; Fibrinogen; Heart Diseases; Humans; Immunohistochemistry; Kidney Diseases; Male; Middle Aged; Mutation | 2008 |
C-reactive protein and all-cause mortality--the Copenhagen City Heart Study.
Topics: Aged; Biomarkers; C-Reactive Protein; Cause of Death; Denmark; Female; Fibrinogen; Genotype; Heart Diseases; Humans; Male; Middle Aged; Polymorphism, Genetic; Proportional Hazards Models; Prospective Studies; Risk Factors | 2010 |
Association between lipids and fibrinogen levels and ischemic stroke in the population of the Polish children with arteriopathy and cardiac disorders.
Topics: Adolescent; Child; Cohort Studies; Comorbidity; Female; Fibrinogen; Heart Diseases; Humans; Lipid Metabolism; Male; Peripheral Vascular Diseases; Poland; Risk Factors; Stroke; Triglycerides | 2010 |
[Changes of haemostatic parameters in patients with acute cardioembolic stroke].
Topics: Adult; Aged; Antifibrinolytic Agents; Antithrombin III; Arteriosclerosis; Brain Ischemia; Embolism; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Heart Diseases; Hemostasis; Humans; Male; Middle Aged; Plasminogen; Plasminogen Activators; Platelet Aggregation; Serum Globulins; Stroke; Thrombin; von Willebrand Factor | 2011 |
Prevention of postoperative pericardial adhesions with TachoSil.
Topics: Animals; Disease Models, Animal; Drug Combinations; Female; Fibrinogen; Heart Diseases; Pericardium; Postoperative Complications; Postoperative Period; Rabbits; Surgical Sponges; Thoracic Surgical Procedures; Thrombin; Tissue Adhesions | 2013 |
Distinct and concerted functions of von Willebrand factor and fibrinogen in mural thrombus growth under high shear flow.
Topics: Afibrinogenemia; Case-Control Studies; Collagen; Fibrinogen; Heart Diseases; Humans; Kinetics; Microscopy, Video; Perfusion; Platelet Adhesiveness; Stress, Mechanical; Thrombosis; von Willebrand Diseases; von Willebrand Factor | 2002 |
Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the Strong Heart Study.
Topics: Cardiovascular Diseases; Echocardiography; Fibrinogen; Heart Diseases; Humans; Hypertrophy, Left Ventricular; Indians, North American; Longitudinal Studies; Risk Factors; Ventricular Dysfunction, Left | 2003 |
Optimistic for longevity.
Topics: Aged; Attitude; Biomarkers; Chronic Disease; Depression; Diabetes Mellitus; Fibrinogen; Happiness; Health Status; Heart Diseases; Humans; Hydrocortisone; Inflammation; Longevity; Middle Aged | 2005 |
Novel risk factors for heart disease. An interview with Gerald Gau, M.D.
Topics: Biomarkers; C-Reactive Protein; Cholesterol, VLDL; Fibrinogen; Heart Diseases; Homocysteine; Humans; Lipoprotein(a); Risk Factors | 2005 |
Full-mouth tooth extraction lowers systemic inflammatory and thrombotic markers of cardiovascular risk.
Topics: Adult; C-Reactive Protein; Cohort Studies; Diabetes Mellitus; Female; Fibrinogen; Follow-Up Studies; Heart Diseases; Humans; Hyperlipidemias; Hypertension; Inflammation Mediators; Leukocyte Count; Longitudinal Studies; Male; Middle Aged; Periodontitis; Plasminogen Activator Inhibitor 1; Platelet Count; Risk Factors; Smoking; Thrombosis; Tissue Plasminogen Activator; Tooth Extraction | 2006 |
Whole grains, bran, and germ in relation to homocysteine and markers of glycemic control, lipids, and inflammation 1.
Topics: Adult; Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus; Edible Grain; Female; Fibrinogen; Health Surveys; Heart Diseases; Homocysteine; Humans; Inflammation; Insulin; Interleukin-6; Leptin; Lipid Metabolism; Male; Middle Aged; Risk Factors | 2006 |
[Influence of dietary therapy containing sunflower oil fortified with phospholipids on the lipid metabolism in patients with hypertension and obesity].
Topics: Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Female; Fibrinogen; Food, Fortified; Heart Diseases; Humans; Hypertension; Lipid Metabolism; Lipoproteins, LDL; Middle Aged; Obesity; Peptide Fragments; Phospholipids; Plant Oils; Sunflower Oil | 2007 |
Hemorheological background of acetylsalicylic acid resistance.
Topics: Aged; Anticoagulants; Aspirin; Blood Viscosity; Cerebrovascular Disorders; Erythrocyte Aggregation; Female; Fibrinogen; Heart Diseases; Hematocrit; Hemorheology; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Assessment | 2008 |
Hemostatic factors and the risk of myocardial infarction.
Topics: Cholesterol, HDL; Fibrinogen; Heart Diseases; Humans; Risk Factors | 1995 |
Changes of blood viscosity in patients treated with 5-fluorouracil--a link to cardiotoxicity?
Topics: Adult; Aged; Blood Viscosity; Carcinoma, Squamous Cell; Fibrinogen; Fluorouracil; Head and Neck Neoplasms; Heart Diseases; Hematocrit; Humans; Linear Models; Male; Middle Aged | 1995 |
Sialic acid and heart disease.
Topics: Fibrinogen; Heart Diseases; Humans; N-Acetylneuraminic Acid; Sialic Acids | 1993 |
Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study.
Topics: Adult; Angina Pectoris; Cerebrovascular Disorders; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus; Family; Female; Fibrinogen; Heart Diseases; Humans; Hypertension; Intermittent Claudication; Male; Middle Aged; Myocardial Infarction; Risk Factors; Sex Factors | 1993 |
Relation of fibrinogen to presence and severity of coronary artery disease is independent of other coexisting heart disease. The ECAT Angina Pectoris Study Group.
Topics: Coronary Angiography; Coronary Artery Disease; Coronary Disease; Female; Fibrinogen; Heart Diseases; Humans; Male; Middle Aged; Prospective Studies | 1993 |
Transdermal estrogen replacement therapy: beneficial effects on hemostatic risk factors for cardiovascular disease.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Antithrombin III; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrinogen; Fibrinolysis; Follow-Up Studies; Heart Diseases; Hemostasis; Humans; Medroxyprogesterone Acetate; Middle Aged; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Postmenopause; Progesterone Congeners; Prospective Studies; Protein C; Regression Analysis; Risk Factors; Serine Proteinase Inhibitors; Tissue Plasminogen Activator | 1996 |
Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study.
Topics: Aged; Angina Pectoris; Biomarkers; Blood Proteins; Cerebrovascular Disorders; Cholesterol, LDL; Cohort Studies; Comorbidity; Factor VII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Heart Diseases; Humans; Hypertension; Incidence; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Scotland; Smoking; Tissue Plasminogen Activator; von Willebrand Factor | 1997 |
[The significance of heparin concentration measurement during cardiopulmonary bypass--effect of heparin-coated circuit during normothermic bypass].
Topics: Adolescent; Adult; Aged; Antithrombin III; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Child; Dose-Response Relationship, Drug; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Diseases; Heparin; Humans; Middle Aged | 1997 |
Hemostatic markers in heart disease.
Topics: Atrial Fibrillation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Diseases; Hemostasis; Humans | 1998 |
Molecular barriers to biomaterial thrombosis by modification of surface proteins with polyethylene glycol.
Topics: Adsorption; Biocompatible Materials; Collagen; Fibrinogen; Heart Diseases; Humans; Isocyanates; Platelet Adhesiveness; Polyethylene Glycols; Polyethylene Terephthalates; Proteins; Thrombosis | 1998 |
Adjuvant effect of antibodies against von Willebrand Factor, fibrinogen, and fibronectin on staphylokinase-induced thrombolysis as measured using mural thrombi formed in rat mesenteric venules.
Topics: Adjuvants, Immunologic; Animals; Blood Pressure; Fibrinogen; Fibrinolytic Agents; Fibronectins; Heart Diseases; Immune Sera; Immunoglobulin G; Male; Mesenteric Veins; Metalloendopeptidases; Plasminogen Activators; Rats; Rats, Wistar; Thrombolytic Therapy; Thrombosis; von Willebrand Factor | 2000 |
Leisure time physical activity, cardiorespiratory fitness, and plasma fibrinogen concentrations in nonsmoking middle-aged men.
Topics: Adult; Age Factors; Cardiovascular Physiological Phenomena; Cross-Sectional Studies; Exercise; Fibrinogen; Heart Diseases; Humans; Life Style; Male; Middle Aged; Oxygen Consumption; Physical Fitness; Risk Assessment | 2000 |
Inflammatory markers of coronary risk.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Biomarkers; C-Reactive Protein; Cytokines; Fibrinogen; Heart Diseases; Humans; Hypercholesterolemia; Inflammation; Phospholipases A; Risk Factors; Troponin T | 2000 |
Tamoxifen is good for the heart.
Topics: C-Reactive Protein; Clinical Trials as Topic; Estrogen Antagonists; Female; Fibrinogen; Heart Diseases; Humans; Placebos; Tamoxifen | 2001 |
Plasma fibrinogen as a predictor of total and cause-specific mortality in elderly Japanese-American men.
Topics: Aged; Americas; Biomarkers; Cohort Studies; Fibrinogen; Follow-Up Studies; Heart Diseases; Humans; Japan; Male; Middle Aged; Myocardial Ischemia; Neoplasms; Prospective Studies; Risk Factors; Survival Rate | 2001 |
Low tissue plasminogen activator relative to plasminogen activator inhibitor-1 as a marker of cardiac complication in children with Kawasaki disease.
Topics: Acute Disease; Biomarkers; C-Reactive Protein; Child, Preschool; Convalescence; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Diseases; Humans; Immunoglobulins, Intravenous; Infant; Leukocyte Count; Male; Mucocutaneous Lymph Node Syndrome; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Sensitivity and Specificity; Tissue Plasminogen Activator; Ultrasonography | 2001 |
Differences between patients with or without the need for intensive care due to severe odontogenic infections.
Topics: Adult; Analysis of Variance; Blood Sedimentation; C-Reactive Protein; Chi-Square Distribution; Critical Care; Female; Fibrinogen; Focal Infection, Dental; Heart Diseases; Hospitalization; Humans; Leukocyte Count; Lung Diseases; Male; Patient Admission; Risk Factors; Statistics as Topic; Streptococcal Infections | 2001 |
Left ventricular thrombus enhancement after intravenous injection of echogenic immunoliposomes: studies in a new experimental model.
Topics: Animals; Antibodies; Arteriosclerosis; Contrast Media; Dogs; Echocardiography; Fibrinogen; Heart Diseases; Heart Ventricles; Injections, Intravenous; Kinetics; Liposomes; Microscopy, Fluorescence; Observer Variation; Pericardium; Thorax; Thrombosis | 2002 |
Elevated fibrinogen and homocysteine levels enhance the risk of mortality in patients from a high-risk preventive cardiology clinic.
Topics: Aged; Coronary Artery Disease; Cross-Sectional Studies; Female; Fibrinogen; Heart Diseases; Homocysteine; Humans; Longitudinal Studies; Male; Middle Aged; Prevalence; Regression Analysis; Risk Factors; Thrombosis | 2002 |
[Functional changes of platelet and its preservation during and after extracorporeal circulation (author's transl)].
Topics: Adolescent; Adult; Blood Platelets; Child; Child, Preschool; Extracorporeal Circulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Diseases; Humans; Male; Middle Aged; Platelet Adhesiveness; Platelet Aggregation; Platelet Count; Time Factors | 1979 |
Coagulation studies in ulcerative colitis and Crohn's disease.
Topics: Adolescent; Adult; Aged; Antithrombins; Blood Cell Count; Blood Coagulation; Blood Platelets; Colitis, Ulcerative; Colon, Sigmoid; Colonic Diseases; Crohn Disease; Factor V; Factor VIII; Female; Fibrinogen; Heart Diseases; Humans; Ileum; Male; Middle Aged; Rectal Diseases | 1975 |
Periepicardial fibrinolytic activity: relation to cardiac bleeding.
Topics: Aminocaproates; Animals; Blood Coagulation; Blood Coagulation Tests; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cats; Electric Stimulation; Fibrin; Fibrinogen; Fibrinolysis; Heart Diseases; Hemorrhage; Injections, Intravenous; Ischemia; Pericardium; Postoperative Complications; Streptokinase; Ventricular Fibrillation | 1975 |
[Formation of left ventricular thrombus in acute myocardial infarction: significance of the determination of fibrinogen, of products of fibrinogen degradation, and of plasminogen].
Topics: Aged; Female; Fibrinogen; Heart Diseases; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Prospective Studies; Thrombosis | 1992 |
The efficacy of antivenom in prevention of cardiovascular depression and coagulopathy induced by brown snake (Pseudonaja) species venom.
Topics: Animals; Antivenins; Australia; Blood Coagulation; Blood Coagulation Disorders; Blood Pressure; Cardiac Output; Central Venous Pressure; Dogs; Elapid Venoms; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Diseases; Heart Rate; Platelet Count; Thrombocytopenia | 1991 |
Clot spotter. Does a test for fibrinogen predict risk of heart disease?
Topics: Fibrinogen; Heart Diseases; Humans; Immunoassay; Risk Factors | 1991 |
[Assisted circulation by external heterotopic prosthesis as a bridge to heart transplantation].
Topics: Adolescent; Adult; Assisted Circulation; Child; Creatinine; Diuresis; Fibrinogen; Graft Rejection; Heart Diseases; Heart Transplantation; Heart-Assist Devices; Hemodynamics; Humans; Middle Aged; Platelet Count | 1990 |
[Thrombolytic therapy with urokinase--indications and results].
Topics: Coronary Artery Bypass; Factor XIII; Fibrinogen; Fibrinolysis; Follow-Up Studies; Heart Diseases; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Risk; Thrombosis; Urokinase-Type Plasminogen Activator | 1986 |
Increased plasma fibrinopeptide A levels during attacks induced by hyperventilation in patients with coronary vasospastic angina.
Topics: Aged; beta-Thromboglobulin; Coronary Angiography; Coronary Vasospasm; Electrocardiography; Female; Fibrinogen; Fibrinopeptide A; Heart Diseases; Humans; Hyperventilation; Male; Middle Aged; Thrombosis | 1989 |
[Left ventricular thrombi detected by Ga-67-DFO-DAS-fibrinogen imaging and two-dimensional echocardiography].
Topics: Adult; Aged; Deferoxamine; Depth Perception; Echocardiography; Female; Fibrinogen; Gallium Radioisotopes; Heart Diseases; Humans; Male; Middle Aged; Radionuclide Imaging; Starch; Thrombosis | 1989 |
Genetic inheritance and plasma fibrinogen.
Topics: Fibrinogen; Genetic Testing; Heart Diseases; Humans | 1988 |
[Pulmonary regulation of fibrinogen levels in acquired heart defects with pulmonary hypertension].
Topics: Aorta; Fibrinogen; Heart Diseases; Hemodynamics; Humans; Hypertension, Pulmonary; Lung; Pulmonary Artery | 1988 |
[Detection of left ventricular thrombi after acute myocardial infarction using Ga-67-DFO-DAS-fibrinogen].
Topics: Adult; Deferoxamine; Echocardiography; Female; Fibrinogen; Gallium Radioisotopes; Heart Diseases; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Radionuclide Imaging; Starch; Thrombosis | 1988 |
Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study.
Topics: Aged; Coronary Artery Disease; Female; Fibrinogen; Heart Diseases; Humans; Male; Middle Aged; Risk; Smoking | 1987 |
Studies on the blood fibrinolytic system in congestive cardiac failure.
Topics: Adult; Aged; Alpha-Globulins; Arm; Constriction; Female; Fibrin; Fibrinogen; Fibrinolysis; Heart Defects, Congenital; Heart Diseases; Heart Failure; Humans; Macroglobulins; Male; Middle Aged; Plasminogen; Serum Globulins; Trypsin Inhibitors; Veins | 1973 |
The fibrinolytic system in patients with right ventricular failure treated with Novurit.
Topics: Adult; Blood Coagulation; Blood Pressure; Fibrinogen; Fibrinolysis; Heart Diseases; Heart Ventricles; Hematocrit; Humans; Hydrochlorothiazide; Middle Aged; Organomercury Compounds; Plasminogen | 1970 |
Quantitation of secondary fibrinolysis in cyanotic heart disease.
Topics: Cardiac Catheterization; Child; Child, Preschool; Cyanosis; Fibrinogen; Heart Diseases; Hemagglutination Inhibition Tests; Hematocrit; Humans; Pulmonary Heart Disease | 1970 |
[Problem of the differential diagnosis and therapy of climacteric cardiopathy].
Topics: Adult; Aged; Aging; Angina Pectoris; Aspartate Aminotransferases; Blood Sedimentation; Body Temperature; C-Reactive Protein; Climacteric; Coronary Disease; Diagnosis, Differential; Electrocardiography; Estradiol; Female; Fibrinogen; Heart Diseases; Humans; Leukocyte Count; Male; Menopause; Methyltestosterone; Middle Aged; Myocardial Infarction; Pain; Serum Globulins; Testosterone | 1967 |